Compare Globus Medical Inc. Class A Common Stock (GMED) vs Quanta Services Inc (PWR) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

PWR trades at $688.88, down 0.85% on the day, with a bullish technical outlook supported by moving averages and a strong $53B backlog. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth is robust, rising from $17.1B in 2022 to $28.5B in 2025, though valuation multiples like a P/E of 78.82 are elevated. Analyst sentiment is overwhelmingly positive, with 27 buy ratings and a consensus price target of $802.08, implying significant upside.

The outlook for PWR is favorable, driven by infrastructure demand and AI-related data center investments, but risks include high valuation sensitivity, execution challenges from rapid growth, and macroeconomic pressures on capital spending. The stock's near-term performance will hinge on Q3 earnings delivery and margin sustainability.